Aquilo Capital Management, LLC
Follow13F filer, CIK 1591986, SAN FRANCISCO, CA
Aquilo Capital Management, LLC reported $0 across 1 holding for the quarter ended 2025-06-30, in a 13F-HR filed 2025-08-06.
Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001591986-25-000006
- Period
- 2025-06-30
- Reported value
- $0
- Holdings
- 1
- Top 10 weight
- New
- 1
- Sold out
- 13
Largest buys vs the previous quarter
None.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| BLUEPRINT MEDICINES CORPexited | -83,926 | -$7.43M |
| ARWRexited | -550,130 | -$7.01M |
| PTGXexited | -81,692 | -$3.95M |
| KYMRexited | -138,521 | -$3.79M |
| DTILexited | -726,149 | -$3.46M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q2 2025
Share positions as resolved from 13F-HR 0001591986-25-000006, largest first. % of portfolio is the value over $0, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| 00 | 0 | $0 | new | Value filed as zero, left out of ratios.Amount filed as zero, left out of ratios. |
Sold out in Q2 2025
Positions in the previous quarter's report that this quarter's report no longer lists.
| Security | Shares before | Value before | Type |
|---|---|---|---|
| AMGNAMGEN INC | 60,000 | $18.7M | call |
| BLUEPRINT MEDICINES CORPBLUEPRINT MEDICINES CORP | 83,926 | $7.43M | shares |
| ARWRARROWHEAD PHARMACEUTICALS IN | 550,130 | $7.01M | shares |
| PTGXPROTAGONIST THERAPEUTICS INC | 81,692 | $3.95M | shares |
| KYMRKYMERA THERAPEUTICS INC | 138,521 | $3.79M | shares |
| DTILPRECISION BIOSCIENCES INC | 726,149 | $3.46M | shares |
| ARVNARVINAS INC | 360,766 | $2.53M | shares |
| RGNXREGENXBIO INC | 271,302 | $1.94M | shares |
| ADICET BIO INCADICET BIO INC | 2,456,194 | $1.85M | shares |
| BCYCBICYCLE THERAPEUTICS PLC | 171,695 | $1.46M | shares |
| IMTXIMMATICS N.V | 304,902 | $1.38M | shares |
| REPARE THERAPEUTICS INCREPARE THERAPEUTICS INC | 1,293,715 | $1.28M | shares |
| ZYMEZYMEWORKS INC | 84,482 | $1.01M | shares |
How Q2 2025 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001591986-25-000006 | base | 2025-08-06 | acceptance time not in the bulk data set |